Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Placenta ; 48 Suppl 1: S12-S16, 2016 12.
Article in English | MEDLINE | ID: mdl-27094788

ABSTRACT

Workshops are an important part of the IFPA annual meeting, as they allow for discussion of specialized topics. At the IFPA meeting 2015 there were twelve themed workshops, three of which are summarized in this report. These workshops were related to various aspects of placental biology but collectively covered areas of pregnancy pathologies and placental metabolism: 1) nanomedicine applications and exosome biology; 2) xenobiotics and endocrine disruptors and pregnancy; 3) lipid mediators and placental function.


Subject(s)
Endocrine Disruptors/pharmacology , Exosomes/physiology , Nanomedicine , Placenta/drug effects , Female , Humans , Lipids , Placenta/metabolism , Placenta/pathology , Placentation/drug effects , Placentation/physiology , Pregnancy , Xenobiotics
2.
Placenta ; 35 Suppl: S86-92, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24411702

ABSTRACT

Endothelial dysfunction leading to increased vascular tone is implicated in the pathogenesis of cardiovascular disease, hypertension and pregnancy-related complications like preeclampsia and intrauterine growth restriction. Vascular tone is regulated by a balance between vasoconstrictor and vasodilator signals. Some vascular mediators circulate in blood, whereas others are produced by the endothelium and are delivered to the underlying vascular smooth muscle cells (VSMCs). It is proposed that increased permeability of resistance arteries in preeclampsia allows access of circulating vasoactive factors to VSMCs leading to increased vascular tone. This review focuses on the role of sphingosine 1-phosphate (S1P). This sphingolipid enhances the endothelial barrier, but it can also disrupt the barrier under certain conditions. These S1P-mediated effects on the endothelial barrier have been demonstrated in cultured endothelial cells and in isolated venules. They depend on S1P concentrations, the S1P receptors expressed and the vascular bed. However, no studies have examined if vascular tone is regulated by S1P in resistance arteries through changes in endothelial permeability and the leakage of circulating vasoconstrictors. Our recent studies using the pressure myograph system show that access of infused vasoconstrictors to VSMCs is blocked under low S1P concentrations. Pathophysiological levels of infused S1P disrupt the barrier and maximally increase vascular tone by facilitating access of itself and a co-infused vasoconstrictor to the VSMCs. Interestingly, infusion of an intermediate physiological concentration of S1P showed a small increase in endothelial permeability with controlled leakage of a co-infused vasoconstrictor that led to sub-maximal vascular tone development. These and other studies delineate the important role of S1P in the regulation of vascular tone and emphasize how dysfunction of this regulation can lead to pregnancy-related disorders.


Subject(s)
Endothelium, Vascular/metabolism , Lysophospholipids/physiology , Sphingosine/analogs & derivatives , Vasoconstriction , Animals , Blood Vessels/physiology , Female , Humans , Permeability , Pregnancy , Sphingosine/physiology
3.
Am J Physiol Heart Circ Physiol ; 304(2): H183-94, 2013 Jan 15.
Article in English | MEDLINE | ID: mdl-23125213

ABSTRACT

Human cytomegalovirus (HCMV) is associated with vascular diseases in both immunosuppressed and immunocompetent individuals. CMV infections cycle between active and latent phases throughout life. We and others have shown vascular dysfunction during active mouse CMV (mCMV) infections. Few studies have examined changes in physiology during latent CMV infections, particularly vascular responses or whether the negative effects of aging on vascular function and fertility will be exacerbated under these conditions. We measured vascular responses in intact mesenteric and uterine arteries dissected from young, mid-aged, and aged latently mCMV-infected (mCMV genomes are present but infectious virus is undetectable) and age-matched uninfected mice using a pressure myograph. We tested responses to the α(1)-adrenergic agonist phenylephrine, the nitric oxide donor sodium nitroprusside, and the endothelium-dependent vasodilator methacholine. In young latently mCMV-infected mice, vasoconstriction was increased and vasodilation was decreased in mesenteric arteries, whereas both vasoconstriction and vasodilation were increased in uterine arteries compared with those in age-matched uninfected mice. In reproductively active mid-aged latently infected mice, mesenteric arteries showed little change, whereas uterine arteries showed greatly increased vasoconstriction. These vascular effects may have contributed to the decreased reproductive success observed in mid-aged latently mCMV-infected compared with age-matched uninfected mice (16.7 vs. 46.7%, respectively). In aged latently infected mice, vasodilation is increased in mesenteric and uterine arteries likely to compensate for increased vasoconstriction to mediators other than phenylephrine. The novel results of this study show that even when active mCMV infections become undetectable, vascular dysfunction continues and differs with age and artery origin.


Subject(s)
Aging , Cytomegalovirus Infections/physiopathology , Cytomegalovirus/physiology , Mesenteric Arteries/physiopathology , Uterine Artery/physiopathology , Vasoconstriction , Vasodilation , Virus Latency , Age Factors , Animals , Cytomegalovirus Infections/complications , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/metabolism , Cytomegalovirus Infections/virology , Disease Models, Animal , Dose-Response Relationship, Drug , Female , Fertility , Infertility/physiopathology , Infertility/virology , Male , Mesenteric Arteries/drug effects , Mesenteric Arteries/metabolism , Mice , Mice, Inbred C57BL , Myography , Nitric Oxide/metabolism , Pregnancy , Pregnancy Rate , Prostaglandins/metabolism , Uterine Artery/drug effects , Uterine Artery/metabolism , Vasoconstriction/drug effects , Vasoconstrictor Agents/pharmacology , Vasodilation/drug effects , Vasodilator Agents/pharmacology
4.
Placenta ; 31 Suppl: S4-20, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20064659

ABSTRACT

Workshops are an important part of the annual meeting of the International Federation of Placenta Associations (IFPA). At IFPA Meeting 2009 diverse topics were discussed in twelve themed workshops. Topics covered included: immune response to pregnancy; signaling between fetus and placenta; bioactive lipids in placenta; placenta in agricultural species; epigenetics and placentation; trophoblast deportation; glucocorticoids and placental function; endothelium; placental transport; genes and placenta; uteroplacental blood flow and placental stem cells. This report is a full summary of the various topics covered.


Subject(s)
Placenta/physiology , Animals , Congresses as Topic , Female , Maternal-Fetal Exchange , Pregnancy
5.
Am J Physiol Heart Circ Physiol ; 296(4): H937-45, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19181963

ABSTRACT

Human cytomegalovirus (CMV) is implicated in vascular complications through endothelial dysfunction. However, the effect of in vivo infections on vascular function in isolated arteries has not been examined. In pregnancy, systemic and uterine vascular adaptations accommodate increased blood volume through several mechanisms, including decreased sensitivity to vasoconstrictors and increased production of endothelial-dependent vasodilators. We hypothesized that an active in vivo CMV infection would reduce vasodilation of isolated arteries to the endothelial-dependent vasodilator methacholine and increase vasoconstriction to the alpha(1)-adrenergic receptor agonist phenylephrine and that these CMV-induced changes would be accentuated in late pregnancy. A mouse CMV infection model was used to study vascular responses in isolated mesenteric and uterine arteries from nonpregnant and late pregnant mice. In the mouse, CMV is not transmitted to the fetus. Accordingly, there was no evidence of active infection in any fetus examined, even though an active infection was found in salivary glands, uterine and mesenteric arteries, and placentas. Contrary to our hypothesis, increased endothelial-dependent vasodilation was found in mesenteric arteries from infected compared with uninfected nonpregnant and pregnant mice These data implicate active CMV infections in hypotensive disorders. Similarly, increased vasodilation was found in uterine arteries from infected vs. uninfected nonpregnant mice. However, this was completely reversed in infected compared with uninfected late pregnant mice in which vasodilation in uterine arteries was significantly reduced. Uterine arteries from infected pregnant mice also showed increased vasoconstriction to phenylephrine. Maternal infection led to decreased placental weights but had no effect on fetal weights in late pregnancy. These novel data demonstrate abnormal systemic and uterine vascular responses during an active CMV infection in both nonpregnant and late pregnant mice. Importantly, despite reduced placental weights, fetal weights were maintained, suggesting effective intrauterine compensation in the mouse model.


Subject(s)
Arteries/physiology , Arteries/virology , Cytomegalovirus Infections/physiopathology , Mesentery/blood supply , Uterus/blood supply , Vasoconstriction/physiology , Vasodilation/physiology , Animals , Arteries/drug effects , Cytomegalovirus , Disease Models, Animal , Female , Fetal Weight/physiology , Male , Methacholine Chloride/pharmacology , Mice , Mice, Inbred C57BL , Phenylephrine/pharmacology , Placenta/physiology , Pregnancy , Vasoconstriction/drug effects , Vasoconstrictor Agents/pharmacology , Vasodilation/drug effects , Vasodilator Agents/pharmacology , beta-Galactosidase/metabolism
6.
Placenta ; 26 Suppl A: S46-8, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15837067

ABSTRACT

During normal pregnancy, extravillous trophoblast cells invade maternal uterine tissues. The interstitial trophoblast penetrates decidual tissues reaching the inner third of the myometrium. A subset of the interstitial trophoblast, the intramural/endovascular trophoblast transforms uterine spiral arteries into large-bore conduits to enable the adequate supply of nutrients and oxygen to the placenta and thus the fetus. Control of invasion is still a mystery and therefore, in this workshop report already existing concepts as well as new models are discussed. Maternal cells such as macrophages and endothelial cells have a clear impact on trophoblast invasion and apoptosis. However, the trophoblast cells need to be susceptible to undergo apoptosis. Thus, an intrinsic program within the trophoblast needs to be activated before induction from the outside can be successful. Quantification of apoptosis further clarified that apoptosis of interstitial trophoblast is not the ultimate means to lead to pathologically shallow invasion. On the other hand, apoptosis of intramural/endovascular trophoblast seems to be highly relevant for a correct transformation of spiral arteries.


Subject(s)
Apoptosis/physiology , Trophoblasts/cytology , Animals , Arteries/growth & development , Arteries/physiology , Cell Proliferation , Endothelium, Vascular/physiology , Female , Fetal Growth Retardation/pathology , Humans , Macrophage Activation , Macrophages/physiology , Nitric Oxide/physiology , Pre-Eclampsia/pathology , Pregnancy , Signal Transduction , Trophoblasts/physiology , Uterus/blood supply , Vasodilation/physiology
7.
Am J Physiol Heart Circ Physiol ; 289(2): H674-82, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15833805

ABSTRACT

Intrauterine growth restriction (IUGR) increases the risk of cardiovascular disease later in life. Vascular dysfunction occurs in adult offspring from animal models of IUGR including maternal undernutrition, but the influence of reduced fetal oxygen supply on adult vascular function is unclear. Myogenic responses, essential for vascular tone regulation, have not been evaluated in these offspring. We hypothesized that 7-mo-old offspring from hypoxic (12% O(2); H) or nutrient-restricted (40% of control; NR) rat dams would show greater myogenic responses than their 4-mo-old littermates or control (C) offspring through impaired modulation by vasodilators. Growth restriction occurred in male H (P < 0.01), male NR (P < 0.01), and female NR (P < 0.02), but not female H, offspring. Myogenic responses in mesenteric arteries from males but not females were increased at 7 mo in H (P < 0.01) and NR (P < 0.05) vs. C offspring. There was less modulation of myogenic responses after inhibition of nitric oxide synthase (P < 0.05), prostaglandin H synthase (P < 0.005), or both enzymes (P < 0.001) in arteries from 7-mo male H vs. C offspring. Thus reduced vasodilator modulation may explain elevated myogenic responses in 7-mo male H offspring. In contrast, there was increased modulation of myogenic responses in arteries from 7-mo female H vs. C or NR offspring after inhibition of both enzymes (P < 0.05). Thus increased vasodilator modulation may maintain myogenic responses in female H offspring at control levels. In summary, vascular responses in adult offspring from adverse intrauterine environments are impaired in a gender-specific, age-dependent, and maternal insult-dependent manner, with males more profoundly affected.


Subject(s)
Hypoxia/physiopathology , Muscle Development , Muscle Tonus , Muscle, Smooth, Vascular/physiopathology , Pregnancy Complications , Prenatal Exposure Delayed Effects , Sex Characteristics , Animals , Cyclooxygenase Inhibitors/pharmacology , Enzyme Inhibitors/pharmacology , Female , In Vitro Techniques , Male , Malnutrition/physiopathology , Meclofenamic Acid/pharmacology , Mesenteric Arteries/enzymology , Mesenteric Arteries/growth & development , Mesenteric Arteries/physiopathology , Muscle, Smooth, Vascular/enzymology , Muscle, Smooth, Vascular/growth & development , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Pregnancy , Prostaglandin-Endoperoxide Synthases/drug effects , Rats , Rats, Sprague-Dawley
8.
Br J Pharmacol ; 143(2): 276-84, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15326035

ABSTRACT

Sphingosine 1-phosphate (S1P), a bioactive lipid, signals through cell surface receptors to induce vasoconstriction and activate endothelial nitric oxide synthase (eNOS), suggesting a role for S1P in vascular tone modulation. Using a model of aging in female rats, we investigated the vasoactivity of S1P and the roles of eNOS and estrogen replacement in modulation of that vasoactivity. Mesenteric arteries from aged female rats were significantly more sensitive to S1P-induced vasoconstriction than arteries from young female rats, and reached greater maximum constriction (58.2+/-2.98 vs 34.8+/-4.44%; P<0.005). Modulation of this vasoconstriction by pretreating vessels with the NOS inhibitor l-NAME occurred only in young vessels. Ovariectomy reduced the maximum S1P-induced vasoconstriction observed in intact aged rats. Estrogen replacement did not appear to have an independent beneficial effect. However, estrogen replacement did restore nitric oxide modulation of S1P-induced vasoconstriction. Expression of the S1P(1) receptor, through which eNOS can be activated, was reduced in vessels from aged rats. S1P(1) receptor expression was restored in vessels from the estrogen-replaced group. S1P is a novel mediator of vascular tone through induction of both vasoconstriction and vasodilation. Reduced S1P(1) receptor expression on aging vessels may explain reduced eNOS activity, which results in greater sensitivity to S1P-induced vasoconstriction. Estrogen replacement in aging female rats restores both S1P(1) receptor expression and NOS activity, suggesting an important role for estrogen in this novel pathway of vascular tone modulation.


Subject(s)
Aging/physiology , Lysophospholipids/pharmacology , Mesenteric Arteries/drug effects , Sphingosine/analogs & derivatives , Sphingosine/pharmacology , Vascular Resistance/drug effects , Vasoconstriction/drug effects , Animals , Canada , Drug Implants/administration & dosage , Drug Implants/pharmacology , Estradiol/administration & dosage , Estradiol/pharmacology , Estrogen Replacement Therapy/methods , Female , Fluorescent Antibody Technique/methods , Gene Expression/drug effects , Lysophospholipids/genetics , Mesenteric Arteries/pathology , Mesenteric Arteries/physiology , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/drug effects , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase/pharmacology , Nitric Oxide Synthase Type III , Ovariectomy , Rats , Rats, Sprague-Dawley , Receptors, Lysosphingolipid/drug effects , Receptors, Lysosphingolipid/genetics , Receptors, Lysosphingolipid/metabolism , Sphingosine/genetics , Vascular Resistance/physiology , Vasoconstriction/physiology
9.
J Virol ; 76(13): 6710-7, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12050384

ABSTRACT

Human cytomegalovirus (HCMV) is a ubiquitous infectious pathogen that, when transmitted to the fetus in utero, can result in numerous sequelae, including late-onset sensorineural damage. The villous trophoblast, the cellular barrier between maternal blood and fetal tissue in the human placenta, is infected by HCMV in vivo. Primary trophoblasts cultured on impermeable surfaces can be infected by HCMV, but release of progeny virus is delayed and minimal. It is not known whether these epithelial cells when fully polarized can release HCMV and, if so, if release is from the basal membrane surface toward the fetus. We therefore ask whether, and in which direction, progeny virus release occurs from HCMV-infected trophoblasts cultured on semipermeable (3.0-microm-pore-size) membranes that allow functional polarization. We show that infectious HCMV readily diffuses across cell-free 3.0-microm-pore-size membranes and that apical infection of confluent and multilayered trophoblasts cultured on these membranes reaches cells at the membrane surface. Using two different infection and culture protocols, we found that up to 20% of progeny virus is released but that <1% of released virus is detected in the basal culture chamber. These results suggest that very little, if any, HCMV is released from an infected villous trophoblast into the villous stroma where the virus could ultimately infect the fetus.


Subject(s)
Cell Polarity/physiology , Cytomegalovirus/physiology , Trophoblasts/virology , Cell Culture Techniques/methods , Cells, Cultured , Chorionic Villi , Cytomegalovirus Infections/virology , Humans , Micropore Filters , Microscopy, Confocal
10.
Placenta ; 22(1): 70-9, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11162355

ABSTRACT

An effective in vitro model of the placental villous syncytium cultured on semi-permeable substrata is essential for studies of infectious pathogen transmission from mother to fetus. Current models using amniotic membranes or thinner artificial membranes show significant leakage, suggesting disruption of tight junctions or the presence of gaps between syncytial units. Such disruption and discontinuity of trophoblast cultures are probably the result of high stromal cell contamination, poor viability and lack of proliferation in culture. We have successfully cultured confluent layers of tight-junctioned syncytium on semi-permeable insert membranes using highly viable purified cytotrophoblasts and an alternating multiple seeding and differentiation technique. Using criteria including transepithelial diffusion of high and low molecular weight substances, electrical resistance and directional secretion of the matrix metalloproteinase, MMP-9, we demonstrate that these cultures form effective and functional physical barriers that can be maintained for up to 1 month.


Subject(s)
Chorionic Villi/metabolism , Membranes, Artificial , Trophoblasts/metabolism , Adult , Animals , Biological Transport , Cells, Cultured , Culture Techniques/methods , Cytomegalovirus/physiology , Dextrans/pharmacokinetics , Diffusion , Dogs , Electric Impedance , Epithelial Cells/cytology , Epithelial Cells/metabolism , Female , Humans , Inulin/pharmacokinetics , Kidney Tubules/cytology , Kidney Tubules/metabolism , Matrix Metalloproteinase 9/metabolism , Models, Biological , Molecular Weight , Particle Size , Pregnancy , Trophoblasts/cytology
12.
J Virol ; 72(6): 4970-9, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9573266

ABSTRACT

Forty percent of women with primary cytomegalovirus (CMV) infections during pregnancy infect their fetuses with complications for the baby varying from mild to severe. How CMV crosses the syncytiotrophoblast, the barrier between maternal blood and fetal tissue in the villous placenta, is unknown. Virus may cross by infection of maternal cells that pass through physical breaches in the syncytiotrophoblast or by direct infection of the syncytiotrophoblast, with subsequent transmission to underlying fetal placental cells. In this study, we show that pure (>99.99%), long-term and healthy (>3 weeks) cultures of syncytiotrophoblasts are permissively infected with CMV. Greater than 99% of infectious progeny virus remained cell associated throughout culture periods up to 3 weeks. Infection of term trophoblasts required a higher virus inoculum, was less efficient, and progressed more slowly than parallel infections of placental and human embryonic lung fibroblasts. Three laboratory strains (AD169, Towne, and Davis) and a clinical isolate from a congenitally infected infant all permissively infected trophoblasts, although infection efficiencies varied. The infection of first trimester syncytiotrophoblasts with strain AD169 occurred at higher frequency and progressed more rapidly than infection of term cells but less efficiently and rapidly than infection of fibroblasts. These results show that villous syncytiotrophoblasts can be permissively infected by CMV but that the infection requires high virus titers and proceeds slowly and that progeny virus remains predominantly cell associated.


Subject(s)
Chorionic Villi/virology , Cytomegalovirus Infections , Trophoblasts/virology , Cells, Cultured , Cytomegalovirus/pathogenicity , Female , Fibroblasts/virology , Humans , Pregnancy , Pregnancy Trimester, First , Virulence
14.
J Virol ; 71(9): 6359-72, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9261353

ABSTRACT

Whether cell-free human immunodeficiency virus type 1 (HIV-1) can productively infect placental trophoblasts (which in turn could transmit the virus into the fetal circulation) is controversial but essential to know for the evaluation of alternative routes (such as cell-mediated infection or trophoblast damage). We have addressed infection factors such as cell purity, source, culture methods, and activation states as well as virus variant and detection methods to conclusively determine the outcome of trophoblast challenge by free virus. Pure (> 99.98%) populations of trophoblasts from 11 different placentas were challenged at a multiplicity of infection (MOI) as high as 6 with five different HIV-1 variants, three of which are non-syncytium-forming, macrophage-tropic isolates from infected infants, with and without coinfection with cytomegalovirus; these preparations were monitored for productive infection for up to 3 weeks after challenge by five different criteria, the most sensitive of which were cocultivation with target cells that can detect virus at an MOI of 10(-7) and HIV DNA PCR that detects 30 virus copies per 10(5) cells. Infection was never detected. However, molecularly cloned T-cell (pNL4-3)- and macrophage (pNLAD8)-tropic provirus plasmids, when transfected into primary trophoblasts, yielded productive infections, indicating that trophoblasts do not suppress late-stage virus replication and assembly. Because of the purity of the trophoblast preparations, the extended length of the infection culture period, the number of trophoblast preparations and virus types examined, the sensitivity of the bioassays and molecular detection assays, and the observations that trophoblasts can support virus replication from provirus, the results of this study strongly argue that free virus cannot infect primary villous trophoblasts.


Subject(s)
Cytomegalovirus/physiology , HIV-1/physiology , Proviruses/physiology , Trophoblasts/virology , Cell Membrane/virology , Cells, Cultured , Coculture Techniques , Cytoplasm/virology , DNA, Viral/metabolism , Genetic Variation , HIV-1/isolation & purification , HeLa Cells , Humans , Infant , Macrophages/virology , Proviruses/genetics , Recombination, Genetic , T-Lymphocytes/virology , Transfection , Trophoblasts/cytology , Virus Replication
15.
Biol Reprod ; 55(2): 400-9, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8828846

ABSTRACT

Tumor necrosis factor alpha (TNF alpha) induces the apoptotic death of primary villous cytotrophoblasts in culture (Yui et al., Placenta 1994; 15:819). Since both p55 and p75 TNF receptors (TNFRs) localize to the villous trophoblast, we examined their roles in mediating trophoblast apoptosis. Comparison of 125I-TNF alpha binding competition by receptor-specific antibodies revealed 2.7-fold more TNFRp75 than TNFRp55. Immunohistochemical analysis of receptor distribution showed TNFRp75 to be expressed strongly in < 20% of cells and TNFRp55 moderately in approximately 50%. Culture with TNF alpha increased the percentage of cells expressing TNFRp75 to > 40% but had little effect on TNFRp55 expression. Agonistic anti-TNFRp55 antibody and TNFRp55-specific TNF mutant protein stimulated both apoptosis and loss of trophoblast viability. In contrast, TNFRp75-specific mutant TNF alpha protein failed to induce either of these responses. Furthermore, neither cell death nor apoptosis stimulated by wild-type TNF alpha was inhibited by an antagonistic anti-TNFRp75 antibody. Thus, the apoptotic death of primary cytotrophoblasts is mediated almost entirely by TNFRp55, and the p75 receptor appears to have little effect on the process.


Subject(s)
Receptors, Tumor Necrosis Factor/analysis , Receptors, Tumor Necrosis Factor/physiology , Signal Transduction/physiology , Trophoblasts/chemistry , Antibodies/metabolism , Antibodies/pharmacology , Apoptosis/physiology , Binding, Competitive , Cells, Cultured , Female , Humans , Immunohistochemistry , Iodine Radioisotopes , Kinetics , Pregnancy , Recombinant Proteins/metabolism , Tumor Necrosis Factor-alpha/metabolism , Tumor Necrosis Factor-alpha/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL